NCT01431547 2016-06-17Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)Merck Sharp & Dohme LLCPhase 1 Completed21 enrolled